AbstractThree mouse monoclonal antibodies (mAb) were produced against soluble recombinant vaccinia virus gp140 from SIVmac251. Two mAbs (1B9 and 6C11) were mapped at the aa 411-430 sequence within the V4 domain, and the third mAb (3C8) recognizes a conformation-dependent epitope on the external envelope glycoprotein. This was shown by its loss of reactivity in Western blot and ELISA with dithiothreitol-reduced gp140. mAb 308, but not 1B9 and 6011, cross-reacts well with gp140 and gp125 from HIV-2ROD, indicating that this discontinuous epitope includes conserved regions localized within the external envelope glycoprotein. Analysis of the neutralizing activities of the mAbs showed that only mAb 1B9 is able to inhibit both syncytium formation ...
An analysis of the humoral immunogenicity of a candidate AIDS vaccine (VaxSyn) in a murine model sys...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
AbstractThree mouse monoclonal antibodies (mAb) were produced against soluble recombinant vaccinia v...
In an attempt to generate broadly cross-reactive, neutralizing monoclonal antibodies (MAbs) to simia...
The determinants of immune recognition by five monoclonal antibodies (KK5, KK9, KK17, Senv7.1, and S...
AbstractTwenty-five conformation-dependent monoclonal antibodies (MAbs) produced by immunization of ...
The external domain of the envelope glycoprotein, gp120, of simian immunodeficiency virus (SIV) has ...
HIV-1 neutralizing monoclonal antibodies (MAbs) define key targets for vaccine development and are b...
Eleven rat monoclonal antibodies (MAbs) that recognize the SU glycoprotein of human immunodeficiency...
Envelope glycoprotein is the primary target for human immunodeficiency virus (HIV) vaccine design. T...
It has been shown previously that the major neutralizing epitopes in simian immunodeficiency virus (...
AbstractEleven anti-HIV Env monoclonal antibodies (MAbs) were isolated from mice immunized with solu...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
Despite considerable interest in the isolation of mAbs with potent neutralization activity against p...
An analysis of the humoral immunogenicity of a candidate AIDS vaccine (VaxSyn) in a murine model sys...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
AbstractThree mouse monoclonal antibodies (mAb) were produced against soluble recombinant vaccinia v...
In an attempt to generate broadly cross-reactive, neutralizing monoclonal antibodies (MAbs) to simia...
The determinants of immune recognition by five monoclonal antibodies (KK5, KK9, KK17, Senv7.1, and S...
AbstractTwenty-five conformation-dependent monoclonal antibodies (MAbs) produced by immunization of ...
The external domain of the envelope glycoprotein, gp120, of simian immunodeficiency virus (SIV) has ...
HIV-1 neutralizing monoclonal antibodies (MAbs) define key targets for vaccine development and are b...
Eleven rat monoclonal antibodies (MAbs) that recognize the SU glycoprotein of human immunodeficiency...
Envelope glycoprotein is the primary target for human immunodeficiency virus (HIV) vaccine design. T...
It has been shown previously that the major neutralizing epitopes in simian immunodeficiency virus (...
AbstractEleven anti-HIV Env monoclonal antibodies (MAbs) were isolated from mice immunized with solu...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
Despite considerable interest in the isolation of mAbs with potent neutralization activity against p...
An analysis of the humoral immunogenicity of a candidate AIDS vaccine (VaxSyn) in a murine model sys...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...